965 results on '"Sohn, Young H."'
Search Results
2. Hypoperfusion in Alzheimer’s Disease–Prone Regions and Dementia Conversion in Parkinson’s Disease
3. Patterns of regional cerebral hypoperfusion in early Parkinson's disease: Clinical implications
4. Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson’s disease
5. Differential effects of cholesterol levels on cognition according to body mass index in Parkinson’s disease
6. Different effect of hypo- and hypermetabolism on cognition in dementia with Lewy bodies: are they coupled or independent?
7. Regional Burden of Enlarged Perivascular Spaces and Cognition and Neuropsychiatric Symptoms in Drug-Naive Patients With Parkinson Disease
8. White matter connectivity networks predict levodopa-induced dyskinesia in Parkinson’s disease
9. Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson’s disease
10. Implication of EEG theta/alpha and theta/beta ratio in Alzheimer’s and Lewy body disease
11. Local striatal volume and motor reserve in drug-naïve Parkinson’s disease
12. Identifying the white matter structural network of motor reserve in early Parkinson's disease
13. Does dopamine deficiency affect sex-dependent prognosis in Parkinson's disease?
14. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease
15. Hypoperfusion in Alzheimer's Disease-Prone Regions and Dementia Conversion in Parkinson's Disease.
16. Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease
17. Comparing MoCA Performance in Parkinson’s disease: Age and Education-Adjusted Cutoffs vs. Machine Learning
18. Development and Validation of a Screening Questionnaire for Dementia With Lewy Bodies (DLB): the DLB Screening Questionnaire (DLBSQ)
19. Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease
20. Functional Brain Networks of Minor and Well‐Structured Major Hallucinations in Parkinson's Disease
21. Different patterns of β-amyloid deposition in patients with Alzheimer's disease according to the presence of mild parkinsonism
22. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease
23. The pattern of FP-CIT PET in pure white matter hyperintensities–related vascular parkinsonism
24. Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra
25. Presentations of nonmotor symptoms by sex and onset age in people with Parkinson's disease.
26. Donepezil for mild cognitive impairment in Parkinson’s disease
27. Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies
28. Initial motor reserve and long-term prognosis in Parkinson's disease
29. Gender-specific effect of urate on white matter integrity in Parkinson's disease
30. Patterns of olfactory functional networks in Parkinson's disease dementia and Alzheimer's dementia
31. Impaired functional connectivity of sensorimotor network predicts recovery in drug-induced parkinsonism
32. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns
33. Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical Atrophy, and Cognitive Dysfunction Across the AD Continuum
34. Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's Disease: An Early‐Phase 18F‐FP‐CIT PET Study
35. Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment
36. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease
37. Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients
38. Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease
39. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease
40. Functional Brain Networks of Minor and Well‐Structured Major Hallucinations in Parkinson's Disease.
41. Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson Disease: An Early Phase 18F‐FP‐CIT Positron Emission Tomography Study.
42. Is the cingulate island sign a marker for early dementia conversion in Parkinson's disease?
43. Distinct amyloid-dependent patterns of nigra dopamine depletion in Lewy body diseases
44. Occipital Amyloid Deposition Is Associated with Rapid Cognitive Decline in the Alzheimer’s Disease Continuum
45. Differential Implications of Cerebral Hypoperfusion and Hyperperfusion in Parkinson's Disease
46. Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off
47. Gender-specific effect of uric acid on resting-state functional networks in de novo Parkinson's disease
48. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease
49. Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson’s disease
50. Distinct FP-CIT PET patterns of Alzheimer’s disease with parkinsonism and dementia with Lewy bodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.